Beneficial cross-protection of allergen-specific immunotherapy on airway eosinophilia using unrelated or a partial repertoire of allergen(s) implicated in experimental feline asthma

Veterinary Journal

Volumn 192, Issue 3, 2012, Pages 412-416

  Reinero, Carol ^a   Lee Fowler, Tekla ^a   Chang, Chee Hoon ^a   Cohn, Leah ^a   DeClue, Amy ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

Allergy; Animal model; Interleukin 10; T regulatory cells; Tolerance

Indexed keywords

ALLERGEN; BERMUDA GRASS ALLERGEN; HOUSE DUST ALLERGEN; INTERLEUKIN 10; PLACEBO; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; ASTHMA; CAT; CONTROLLED STUDY; CROSS PROTECTION; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG DOSE ESCALATION; DRUG EFFICACY; EOSINOPHILIA; FEMALE; HOUSE DUST ALLERGY; IMMUNOASSAY; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; LUNG LAVAGE; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; REGULATORY T LYMPHOCYTE; RESPIRATORY TRACT INFLAMMATION; RUSH IMMUNOTHERAPY;

ALLERGENS; ANIMALS; ASTHMA; BRONCHI; BRONCHOALVEOLAR LAVAGE FLUID; CAT DISEASES; CATS; CELL PROLIFERATION; CROSS REACTIONS; CYNODON; DERMATOPHAGOIDES FARINAE; EOSINOPHILIA; FEMALE; IMMUNOTHERAPY, ACTIVE; LYMPHOCYTES; MALE;

ANIMALIA; CYNODON DACTYLON; FELIDAE; PYROGLYPHIDAE;

EID: 84861867384     PISSN: 10900233     EISSN: 15322971     Source Type: Journal    
DOI: 10.1016/j.tvjl.2011.07.003     Document Type: Article

References (21)

1. Akdis M., Verhagen J., Taylor A., Karamloo F., Karagiannidis C., Crameri R., Thunberg S., Deniz G., Valenta R., Fiebig H., Kegel C., Disch R., Schmidt-Weber C., Blaser K., Akdis C.A. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. Journal of Experimental Medicine 2004, 199:1567-1575.
2. Akdis M., Akdis C.A. Mechanisms of allergen-specific immunotherapy. Journal of Allergy and Clinical Immunology 2007, 119:780-791.
3. Akoum H., Tsicopoulos A., Vorng H., Wallaert B., Dessaint J., Joseph M., Hamid Q., Tonnel A. Venom immunotherapy modulates interleukin-4 and interferon-γ messenger RNA expression of peripheral T lymphocytes. Immunology 1996, 87:593-598.
4. Domdey A., Liu A., Millner A., Lund K., Jacobi H., Malling H., Sondergaard I., Wurtzen P. The T cell response to major grass allergens is regulated and includes IL-10 production in atopic but not in non-atopic subjects. International Archives of Allergy and Immunology 2010, 152:243-254.
5. Fujiwara S., Yasunaga S., Iwabuchi S., Masuda K., Ohno K., Tsujimoto H. Cytokine profiles of peripheral blood mononuclear cells from dogs experimentally sensitized to Japanese cedar pollen. Veterinary Immunology and Immunopathology 2003, 93:9-20.
6. GroB R., Metzner G., Behn U. Mathematical modeling of allergy and specific immunotherapy: Th1-Th2-Treg interactions. Journal of Theoretical Biology 2010, 269:70-78.
7. Jain V., Businga I., Kitagaki K., George C., O'Shaughnessy P., Kline J. Mucosal immunotherapy with CpG oligodeoxynucleotides reverses a murine model of chronic asthma induced by repeated antigen exposure. American Journal of Physiology - Lung Cellular and Molecular Physiology 2003, 285:L1137-L1146.
8. James L., Durham S. Update on mechanisms of allergen injection immunotherapy. Clinical and Experimental Allergy 2008, 38:1074-1088.
9. Kim H., DeKruyff R.H., Umetsu D.T. The many paths to asthma: Phenotype shaped by innate and adaptive immunity. Nature Immunology 2010, 11:577-584.
10. Kirschvink N., Leemans J., Delvaux F., Snaps F., Clercx C., Gustin P. Functional, inflammatory and morphologic characterisation of a cat model of allergic airway inflammation. The Veterinary Journal 2007, 174:541-553.
11. Lee-Fowler T., Cohn L., DeClue A., Reinero C. Evaluation of subcutaneous versus mucosal (intranasal) allergen-specific rush immunotherapy in experimental feline asthma. Veterinary Immunology and Immunopathology 2009, 129:49-56.
12. Ling E., Smith T., Nguyen X., Pridgeon C., Dallman M., Arbery J., Carr V.A., Robinson D.S. Relation of CD4+CD25+regulatory T-cell suppression of allergen driven T-cell activation to atopic status and expression of allergic disease. Lancet 2004, 363:608-615.
13. Meiler F., Zumkehr J., Klunker S., Ruckert B., Akdis C.A., Akdis M. In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure. Journal of Experimental Medicine 2008, 205:2887-2898.
14. Norris Reinero C., Decile K., Berghaus R., Williams K., Leutenegger C., Walby W., Schelegle E., Hyde D., Gershwin L. An experimental model of allergic asthma in cats sensitized to house dust mite or Bermuda grass allergen. International Archives of Allergy and Immunology 2004, 135:117-131.
15. Padrid P., Snook S., Finucane T., Shiue P., Cozzi P., Solway J., Leff A.R. Persistent airway hyperresponsiveness and histologic alterations after chronic antigen challenge in cats. American Journal of Respiratory and Critical Care Medicine 1995, 151:184-193.
16. Prigione I., Morandi F., Tosca M., Silvestri M., Pistoia V., Ciprandi G., Rossi G. Interferon-gamma and IL-10 may protect from allergic polysensitization in children: Preliminary evidence. Allergy 2009, 65:740-742.
17. Reinero C.R., Byerly J.R., Berghaus R.D., Berghaus L.J., Schelegle E.S., Hyde D.M., Gershwin L.J. Rush immunotherapy in an experimental model of feline allergic asthma. Veterinary Immunology and Immunopathology 2006, 110:141-153.
18. Reinero C., Cohn L., Delgado C., Spinka C., Schooley E., DeClue A. Adjuvanted rush immunotherapy using CpG oligodeoxynucleotides in experimental feline allergic asthma. Veterinary Immunology and Immunopathology 2008, 121:241-250.
19. Reinero C. Advances in the understanding of pathogenesis, and diagnostics and therapeutics for feline allergic asthma. The Veterinary Journal 2010, 190:28-33.
20. Tarzi M., Klunker S., Texier C., Verhoef A., Stapel S., Akdis C., Maillere B., Kay A., Larche M. Induction of interleukin-10 and suppressor of cytokine signalling-3 gene expression following peptide immunotherapy. Clinical and Experimental Allergy 2006, 36:465-474.
21. Thornton A., Shevach E. Suppressor effector function of CD4+CD25+immunoregulatory T cells is antigen nonspecific. Journal of Immunology 2000, 164:183-190.